ALK and non-small cell lung carcinoma: Previous studies have reported that EGFR and ALK double mutations have been found in the minority of patients with non-small-cell lung cancer (Koivunen et al., 2008), in which patients with double mutations have shorter OS values than patients with EGFR or ALK single mutations (Lou et al., 2016).